RPG Life Sciences Share Price
04 Sep, 2026 3:50 PM (IST)
RPG Life Sciences Performance
- Today's Low
- ₹2,639
- Today's High
- ₹2,739
- 52 Week Low
- ₹1,733
- 52 Week High
- ₹3,082
- Open Price₹2,652
- Previous Close₹2,652
- Volume21,607
- 50 DMA₹2,617.10
- 100 DMA₹2,495.40
- 200 DMA₹2,374.70
RPG Life Sciences Chart
Investment Returns
- Over 1 Month + 0.51%
- Over 3 Month + 25.91%
- Over 6 Month + 45.08%
- Over 1 Year + 14.45%
Smart Investing Starts Here Start SIP with RPG Life Sciences for Steady Growth!
RPG Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 37.6
- PEG Ratio
- -
- Market Cap Cr
- 4,501
- P/B Ratio
- 7.1
- Average True Range
- 97.4
- EPS
- 72.3
- Dividend Yield
- 0.9
- MACD Signal
- -18.6
- RSI
- 55.69
- MFI
- 50.69
Latest Stock News Updates
Drug firm RPG Life Sciences is planning to deploy Rs 500 crore over the next 12 months to strengthen its manufacturing and API capabilities through strategic acquisitions. In an interview with PTI, RPG Life Sciences Managing Director Ashok Nair said the company has embarked on a significant expansion phase, backed by a committed capital infusion of Rs 700 crore. "Currently, the acquisitions we have made are to the tune of Rs 200 crore. We are evaluating opportunities that can strengthen our manufacturing footprint. We would like to deploy the Rs 500 crore balance in the next 12 months. We are actively pursuing good assets," Nair said. The company, which operates across domestic and international formulations and Active Pharmaceutical Ingredients (APIs), has set a target of reaching Rs 2,000 crore- 2,500 crore in revenue by 2030. Nair noted that the company started FY27 on a strong footing, recording 16 per cent revenue growth and 18 per cent EBITDA growth in the first quarter. The
- Business Standard
- 53 minutes 21 seconds ago
The drugmaker has more than 500 crore of capital available and is evaluating businesses that can add differentiated chemistry, regulatory access and export capabilities
- Business Standard
- 22 hours 42 minutes ago
Update on Analyst/Institutional call
- BSE India
- 2 days 2 hours ago
RPG Life Sciences Financials
RPG Life Sciences Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹2,649.80
- 50 Day
- ₹2,617.10
- 100 Day
- ₹2,495.40
- 200 Day
- ₹2,374.70
Resistance and Support
- R3 2,860.90
- R2 2,799.90
- R1 2,760.80
- S1 2,660.70
- S2 2,599.70
- S3 2,560.60
RPG Life Sciences Corporate Actions - Bonus, Splits, Dividends
About RPG Life Sciences
RPG Life Sciences is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). View More- NSE Symbol
- RPGLIFE
- BSE Symbol
- 532983
- ISIN
- INE105J01010
Similar Stocks to RPG Life Sciences
Popular Stocks
RPG Life Sciences FAQs
RPG Life Sciences share price is ₹2,721 As on 06 September, 2026 | 11:20
The Market Cap of RPG Life Sciences is ₹4501.3 Cr As on 06 September, 2026 | 11:20
The P/E ratio of RPG Life Sciences is 37.6 As on 06 September, 2026 | 11:20
The PB ratio of RPG Life Sciences is 7.1 As on 06 September, 2026 | 11:20
The 52 week High & Low of RPG Life Sciences is ₹3082/₹1733 respectively As on 06 September, 2026 | 11:20
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.